The Caco-2 Cell Monolayers as an Intestinal Metabolism Model: Metabolism of Dipeptide Phe-Pro

References

• Artursson P. Epithelial transport of drugs in cell culture. I: A model for studying the passive absorption of drugs over intestinal absorptive (Caco-2) cells. J. Pharm. Sri. (1990); 79: 476–182
   PubMed Web of Science ®Google Scholar
• Bai J. P.F., Hu M., Subramanian P., Mosberg H., Amidon G. L. Utilization of peptide carrier system to improve intestinal absorption: targeting prolidase as a prodrug-converting enzyme. J. Pharm. Sci. (1992); 81: 113–116
   PubMed Web of Science ®Google Scholar
• Beaulieu J. F., Quaroni A. Clonal analysis of sucrase-isomaltase expression on the human colon adenocarcinoma Caco-2 cells. Biochem. J. (1991); 280: 599–608
   PubMed Web of Science ®Google Scholar
• Bergan T. Pharmacokinetic properties of the cephalosporins. Drugs. (1987); 34(suppl 2)89–104
   PubMedGoogle Scholar
• Bradford M. A rapid and sensitive method for the determination of microgram quantities of protein utilizing the principles of protein-dye binding. Anal. Biochem. (1976); 72: 248–254
   PubMed Web of Science ®Google Scholar
• Dantzig A. H., Bergin L. Uptake of the cephalosporin, cephalexin, by a dipeptide transport carrier in the human intestinal cell line, Caco-2. Biochim. Biophys. Acta (1990); 1027: 211–217
   PubMed Web of Science ®Google Scholar
• Darmoul D., Lacasa M., Baricault L., Marguet D., Sapin C., Trotot P., Barbat A., Trugnan G. Dipeptidyl peptidase IV (CD 26) gene expression on enterocyte-like colon cancer cell lines HT29 and Caco-2. J. Biol. Chem. (1992); 267: 4824–4833
   PubMed Web of Science ®Google Scholar
• Hidalgo I. J., Raub T. J., Borchardt R. T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology (1989); 96: 736–49
   PubMed Web of Science ®Google Scholar
• Howell S., Kenny A. J., Turner A. J. A survey of membrane peptidases in two human colonic cell lines, Caco-2 and HT-29. Biochem. J. (1992); 284: 595–601
   PubMed Web of Science ®Google Scholar
• Hu M., Amidon G. L. Passive and carrier-mediated intestinal absorption components of captopril. J. Pharm. Sri. (1988); 77: 1007–1011
   PubMed Web of Science ®Google Scholar
• Hu M., Borchardt R. T. Mechanism of L-α-methyldopa transport through a monolayer of polarized human intestinal epithelial cells (Caco-2). Pharm. Res. (1990); 7: 1313–1319
   PubMed Web of Science ®Google Scholar
• Hu M., Borchardt R. T. Transport of a Large Neutral Amino Acid in a Human Intestinal Epithelial Cell Line (Caco-2): Uptake and Efflux of Phenylalanine. Biochim. Biophys. Acta (1992); 1135: 233–244
   PubMed Web of Science ®Google Scholar
• Hu M. Comparison of Uptake Characteristics of Thymidine and Zidovuldine in a Human Intestinal Epithelial Model System. J. Pharm. Sci. (1993); 82: 829–933
   PubMed Web of Science ®Google Scholar
• Inui K., Okano T., Maegawa H., Kato M., Takano M., Hori R. H + -Coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine. J. Pharmacol. Expt. Ther. (1988); 246: 235–241
   PubMedGoogle Scholar
• Inui K., Yamamoto M., Saito H. Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: Specific transport systems in apical and basolateral membranes. J. Pharmacol. Expt. Ther. (1992); 261: 195–201
   PubMed Web of Science ®Google Scholar
• Iseki K., Sugawara M., Saitoh H., Miyazaki K., Arita T. Comparison of transport characteristics of amino β-lactam antibiotics and dipeptide across rat intestinal brushborder membrane. J. Pharm. Pharmacol. (1989); 41: 628–632
   PubMed Web of Science ®Google Scholar
• Kelly J. G., O'Malley K. Clinical Pharmacokinetics of the newer ACE inhibitors. Clin. Pharmacokinet (1990); 19: 177–196
   PubMed Web of Science ®Google Scholar
• Kempf D. J., Marsh K. C., Paul D. A., Knigge M. F., Norbeck D. W., Kohlbrenner W. E., Codacovi L., Vasavanonda S., Bryant P., Wang X-C, Wideburg N. E., Clement J. J., Plattner J. J., Erickson J. Antiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 protease. Antimicro. Agents and Chemother. (1991); 35: 2209–2214
   PubMed Web of Science ®Google Scholar
• Kleinert H. D., Rosenberg S. H., Baker W. R., Stein H. H., Klinghofer V., Barlow J., Spina K., Polakowski J., Kovar P., Cohen J., Denissen J. Discovery of a peptide-based renin inhibitor with oral bioavailability and efficacy. Science (1992); 257: 1940–1943
   PubMed Web of Science ®Google Scholar
• Kleinert H. D., Baker W. R., Stein H. H. Orally bioavailable peptide like molecules: A case history. Biopharm. (1993); 6: 36–41
   Google Scholar
• Kohl N. E., Mosser S. D., de Solms S. J., Giuliani E. A., Pompliano D. L., Graham S. L., Smith R. L., Scolnick E. M., Oliff A., Gibbs J. B. Selective inhibition of ras-dependent transformation by a fanesyltransferase inhibitor. Science (1993); 260: 1934–1937
   PubMed Web of Science ®Google Scholar
• Kostis J. B., Raia J. J., Jr, De Felice E. A., Barone J. A., Deeter R. G. Comparative clinical pharmacology of ACE inhibitors. Angiotensin Converting Enzyme Inhibitors, J. B. Kostis, E. A. De Felice. Alan R. Liss, Inc., New York (1987); 19–54
   Google Scholar
• Kuhfeld M. T., Chen J., Hu M., Stratford R. E., Jr. Design of a novel diffusion apparatus compatible with Millicell permeable support and its characterization using Caco-2 cells. AAPS 7th National Meeting. Orlando, FL. 1993
   Google Scholar
• Metcalf G., Jackson O. M.D. Thyrotropin-releasing hormone. Biomedical significance. Ann NY Acad. Sci. (1989); 553: 1–631
   Google Scholar
• Myara I., Charpentier C., Lamonnier A. Prolidase and prolidase deficiency. Life Science (1984); 34: 1985–1998
   PubMed Web of Science ®Google Scholar
• Nicklin P. L., Irwin W. J., Hassan I. F., Mackay M. Proline uptake by monolayers of human absorptive (Caco-2) cells in vitro. Biochim. Biophys. Acta. (1992); 1104: 283–292
   PubMed Web of Science ®Google Scholar
• Pinto M., Robine-Leon S., Appay M. D., Kedinger M., Triadou N., Dussaulx E., Lacroix B., Simon-Assmann P., Haffen K., Fogh J., Zweibaum A. Enterocytelike differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell. (1983); 47: 323–330
   Web of Science ®Google Scholar
• Riley S. A., Warhurst G., Crowe P. T., Turnberg L. A. Active hexose transport across cultured human Caco-2 cells: characterization and influence of culture conditions. Biochim. Biophys. Acta (1991); 1066: 175–182
   PubMed Web of Science ®Google Scholar
• Roberts N. A., Martin J. A., Kinchington D., Broadhusrt A. V., Craig J. C., Duncan I. B., Galpin S. A., Handa B. K., Kay J., Krohn A., Lambert R. W., Merrett J. H., Mills J. S., Parkes K. E.B., Redshaw S., Ritchie A. J., Taylor D. L., Thomas Machin G. J.P.J. Rational design of peptide-based HIV proteinase inhibitors. Science (1990); 248: 358–361
   PubMed Web of Science ®Google Scholar
• Rubino A., Pierro M., LaTorretta G., VetrellaDi M., Martino D., Auricchio S. Studies on intestinal hydrolysis of peptides. II. Dipeptidase activity toward L-glutaminayl-L-proline and glycyl-proline in the small intestine of the human fetus. Pediat Res. (1969); 3: 313–319
   PubMed Web of Science ®Google Scholar
• Segal I. H. Enzyme Kinetics and Analysis of Rapid Equilibrium and Steady-State Enzyme System. John Wiley and Son, New York 1975
   Google Scholar
• Sinko P. J., Amidon G. L. Characterization of the oral absorption of β-lactam antibiotics. I. Cephalosporins: Determination of intrinsic membrane absorption parameters in the rat intestine in situ. Pharm. Res. (1988); 5: 645–650
   PubMed Web of Science ®Google Scholar
• Thwaites D. T., Brown C. D.A., Hirst B. H., Simmons N. L. Transepithelial glycylsarcosine transport in intestinal Caco-2 cells mediated by expression of H+coupled carriers at both apical and basal membranes. J. Biol. Chem. (1993); 268: 7640–7642
   PubMed Web of Science ®Google Scholar
• Trotter P. J., Storch J. Fatty acid uptake and metabolism in a human intestinal cell line (Caco-2): comparison of apical and basolateral incubation. J. Lipid Res. (1991); 32: 293–304
   PubMed Web of Science ®Google Scholar
• Wilson Kassan G. I.F., Dix C. J., Williamson I., Shah R., Mackay M., Artursson P. Transport and permeability properties of human Caco-2 cells: an in vitro model of the intestinal epithelial cell barrier. J. Control. Rel. (1990); 11: 25–40
   Web of Science ®Google Scholar
• Wong K. K., Lan S. J., Migdalof B. H. In vitro biotransformations of [14C]-captopril in the blood of rats, dogs, and humans. Biomed. Pharmacol. (1981); 30: 2643–50
   Google Scholar
• Yoshimoto T., Matsubara F., Kawano E., Tsuru D. Prolidase from bovine intestine: purification and characterization. J. Biochem. (1983); 94: 1889–1896
   PubMed Web of Science ®Google Scholar